Evidence map›Paper›PMID 40237039›Full record

ArticleAmerican journal of physiology. Cell physiology2025

AAV1-CFTR preferentially transduces cysts and reduces cyst size in a mouse model of ADPKD.

Cristian Ciobanu, Liudmila Cebotaru

Abstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Cristian CiobanuDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland, United States.ORCID 0000-0002-5230-6226
Liudmila CebotaruDepartment of Medicine, Johns Hopkins University, Baltimore, Maryland, United States.ORCID 0000-0002-4362-8995

Funding

Developing a New Therapeutic Approach for Autosomal Dominant Polycystic Kidney Disease.R01DK125272 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI CEBOTARU, LIUDMILA · 2020 to 2024
$1.9M
HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) DK125272NIDDK NIH HHS R01 DK125272
6 · The paper itself

Abstract

To overcome the challenges of developing a gene therapy for autosomal dominant polycystic kidney disease (ADPKD), we focused on the surface receptors expressed in cystic epithelia. Importantly, we detected altered localization in the cystic epithelium of wheat germ agglutinin, WGA, staining of sialic acids. Throughout the membrane of the cysts, we saw altered staining with

Indexed as

Cystic Fibrosis Transmembrane Conductance RegulatorCystsDependovirusGenetic TherapyPolycystic Kidney, Autosomal DominantAnimalsDisease Models, AnimalGenetic VectorsHumansMaleMiceMice, Inbred C57BLTransduction, GeneticCftr protein, mouseCystic Fibrosis Transmembrane Conductance RegulatorAAV1ADPKDCFTRkidneysialic acid

Identifiers

PMID40237039
PMCPMC12359046

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.